Gracia-Sancho Jorge, Laviña Bàrbara, Rodríguez-Vilarrupla Aina, García-Calderó Héctor, Fernández Mercedes, Bosch Jaume, García-Pagán Joan-Carles
Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives i Metabòliques (IMDiM), Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University of Barcelona, Spain.
Hepatology. 2008 Apr;47(4):1248-56. doi: 10.1002/hep.22166.
In cirrhotic livers, decreased nitric oxide (NO) bioavailability is a major factor increasing intrahepatic vascular tone. In several vascular disorders, an increase in superoxide (O(2) (-)) has been shown to contribute to reduced NO bioavailability through its reaction with NO to form peroxynitrite. This study was aimed to test the hypothesis that, in cirrhotic livers, increased O(2) (-), by reacting with NO, reduces NO bioavailability. In control and cirrhotic rat livers, NO bioavailability was evaluated by the measurement of cyclic guanosine monophosphate in liver tissue and by 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM-DA) fluorescence in isolated sinusoidal endothelial cells (SEC); the O(2) (-) content was determined by dihydroethidium staining in fresh liver sections. In addition, the role of endothelial nitric oxide synthase (eNOS), xanthine oxidase (XO), and cyclooxygenase (COX) as possible sources of O(2) (-) and the role of superoxide dismutase (SOD) enzymatic activity as an O(2) (-) scavenger were determined in liver homogenates. Protein-nitrotyrosination, a marker of the NO-O(2) (-) reaction, was evaluated in liver homogenates. Furthermore, in control SEC and bovine aortic endothelial cells, NO modulation by O(2) (-) was evaluated. Cirrhotic livers exhibited increased O(2) (-) levels. This was due, at least in part, to increased production by COX and XO but not eNOS and to reduced scavenging by SOD. Increased O(2) (-) was associated with a significant reduction in NO bioavailability and increased nitrotyrosinated proteins. In endothelial cells, an inverse relationship between O(2) (-) levels and NO bioavailability was observed.
Our data show that oxidative stress may contribute to reduced NO bioavailability in cirrhotic livers, supporting the evaluation of O(2) (-) reduction as a potential mechanism to restore NO content.
在肝硬化肝脏中,一氧化氮(NO)生物利用度降低是增加肝内血管张力的主要因素。在几种血管疾病中,超氧化物(O₂⁻)的增加已被证明通过与NO反应形成过氧亚硝酸盐而导致NO生物利用度降低。本研究旨在检验以下假设:在肝硬化肝脏中,增加的O₂⁻通过与NO反应降低NO生物利用度。在对照和肝硬化大鼠肝脏中,通过测量肝组织中环磷酸鸟苷以及分离的肝窦内皮细胞(SEC)中4-氨基-5-甲基氨基-2',7'-二氟荧光素二乙酸酯(DAF-FM-DA)荧光来评估NO生物利用度;通过新鲜肝切片中的二氢乙啶染色测定O₂⁻含量。此外,在肝匀浆中确定了内皮型一氧化氮合酶(eNOS)、黄嘌呤氧化酶(XO)和环氧化酶(COX)作为O₂⁻可能来源的作用以及超氧化物歧化酶(SOD)酶活性作为O₂⁻清除剂的作用。在肝匀浆中评估了蛋白质硝基酪氨酸化,这是NO-O₂⁻反应的标志物。此外,在对照SEC和牛主动脉内皮细胞中评估了O₂⁻对NO的调节作用。肝硬化肝脏中O₂⁻水平升高。这至少部分是由于COX和XO产生增加而非eNOS产生增加,以及SOD清除减少所致。O₂⁻增加与NO生物利用度显著降低和硝基酪氨酸化蛋白质增加相关。在内皮细胞中,观察到O₂⁻水平与NO生物利用度之间呈负相关。
我们的数据表明,氧化应激可能导致肝硬化肝脏中NO生物利用度降低,支持将降低O₂⁻作为恢复NO含量的潜在机制进行评估。